Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Feb;34(2):235–240. doi: 10.1128/aac.34.2.235

Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin.

C E Swenson 1, K A Stewart 1, J L Hammett 1, W E Fitzsimmons 1, R S Ginsberg 1
PMCID: PMC171564  PMID: 2183715

Abstract

Gentamicin sulfate was encapsulated in liposomes composed solely of egg phosphatidylcholine and administered via intravenous injection to rats and mice. The total gentamicin activity (regardless of whether it was free or liposome associated) in serum and selected tissues was determined for 24 h (serum) or up to 15 weeks (tissues) by using a microbiological assay. The mean half-lives in serum of a single 20-mg/kg dose of free (nonencapsulated) gentamicin in mice and rats were estimated to be 1.0 and 0.6 h, respectively, whereas a similar dose of encapsulated drug had apparent mean half-lives of 3.8 h in mice and 4.0 h in rats. In both species, the apparent half-life in serum of the liposomal formulation increased as the dose increased. Liposome encapsulation resulted in higher and more prolonged activity in organs rich in reticuloendothelial cells (especially spleen and liver). In acute septicemia infections in mice, the liposomal formulation showed enhanced prophylactic activity (as determined by calculation of the 50% protective dose). In a model of murine salmonellosis, liposomal gentamicin greatly enhanced survival when given as a single dose (10 mg/kg) at 1 or 2 days after infection as well as up to 7 days before infection.

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker-Woudenberg I. A., Lokerse A. F., Roerdink F. H., Regts D., Michel M. F. Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. J Infect Dis. 1985 May;151(5):917–924. doi: 10.1093/infdis/151.5.917. [DOI] [PubMed] [Google Scholar]
  2. Brown R. D., Manno J. E. ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci. 1978 Dec;67(12):1687–1691. doi: 10.1002/jps.2600671214. [DOI] [PubMed] [Google Scholar]
  3. Cynamon M. H., Swenson C. E., Palmer G. S., Ginsberg R. S. Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother. 1989 Aug;33(8):1179–1183. doi: 10.1128/aac.33.8.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Desiderio J. V., Campbell S. G. Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis. J Reticuloendothel Soc. 1983 Oct;34(4):279–287. [PubMed] [Google Scholar]
  5. Fountain M. W., Weiss S. J., Fountain A. G., Shen A., Lenk R. P. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. J Infect Dis. 1985 Sep;152(3):529–535. doi: 10.1093/infdis/152.3.529. [DOI] [PubMed] [Google Scholar]
  6. Gruner S. M., Lenk R. P., Janoff A. S., Ostro M. J. Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles. Biochemistry. 1985 Jun 4;24(12):2833–2842. doi: 10.1021/bi00333a004. [DOI] [PubMed] [Google Scholar]
  7. Morgan J. R., Williams K. E. Preparation and properties of liposome-associated gentamicin. Antimicrob Agents Chemother. 1980 Apr;17(4):544–548. doi: 10.1128/aac.17.4.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Orozco L. C., Quintana F. O., Beltrán R. M., de Moreno I., Wasserman M., Rodriguez G. The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis. Tubercle. 1986 Jun;67(2):91–97. doi: 10.1016/0041-3879(86)90002-4. [DOI] [PubMed] [Google Scholar]
  9. Saba T. M. Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med. 1970 Dec;126(6):1031–1052. [PubMed] [Google Scholar]
  10. Senior J. H. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst. 1987;3(2):123–193. [PubMed] [Google Scholar]
  11. Swenson C. E., Popescu M. C., Ginsberg R. S. Preparation and use of liposomes in the treatment of microbial infections. Crit Rev Microbiol. 1988;15 (Suppl 1):S1–31. doi: 10.3109/10408418809104463. [DOI] [PubMed] [Google Scholar]
  12. Tadakuma T., Ikewaki N., Yasuda T., Tsutsumi M., Saito S., Saito K. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. Antimicrob Agents Chemother. 1985 Jul;28(1):28–32. doi: 10.1128/aac.28.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Vladimirsky M. A., Ladigina G. A. Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis. Biomed Pharmacother. 1982;36(8-9):375–377. [PubMed] [Google Scholar]
  14. Vogelman B., Gudmundsson S., Leggett J., Turnidge J., Ebert S., Craig W. A. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 1988 Oct;158(4):831–847. doi: 10.1093/infdis/158.4.831. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES